Kentucky to Receive $2.3 Million in Negotiated Drug Settlement
Attorney General Jack Conway has announced the Kentucky will receive $2.3 million dollars in a negotiated settlement with drug manufacturer Cephalon. The settlement arises out of a lawsuit filed by several states Attorneys General that allege the drug company marketed their products for off-label uses to doctors. The drugs involved are Actiq, a painkiller, the anti-epilepsy drug Gabitril and the narcolepsy drug Provigil.
In October, Cephalon agreed to pay over $375 million to settle the civil case, $40 million in criminal fines and forfeited $10 million.